text:
of Health and Human Services
Participating Organizations
National Institutes of Health (NIH) (http://www.nih.gov)
National Heart, Lung and Blood Institute (NHLBI) (www.nhlbi.nih.gov)
Components of
Participating Organizations
National Institute of Nursing Research (NIH) (http://www.ninr.nih.gov)
National Cancer Institute (NCI) (http://www.nci.nih.gov)
Office of Behavioral and Social Sciences Research (OBSSR) (http://obssr.od.nih.gov)
Title: Health Promotion Among Racial and Ethnic Minority Males (R21)
Announcement Type
This is a reissue of PA-03-170, which was previously released September 8, 2003.
Update: The following update relating to this announcement has been issued:
NOTICE: Applications submitted in response to this Funding Opportunity Announcement (FOA) for Federal assistance must be submitted electronically through Grants.gov (http://www.grants.gov) using the SF424 Research and Related (R&R) forms and the SF424 (R&R) Application Guide.
This FOA must be read in conjunction with the application guidelines included with this announcement in Grants.gov/Apply for Grants (hereafter called Grants.gov/Apply).
A registration process is necessary before submission and applicants are highly encouraged to start the process at least four weeks prior to the grant submission date. See Section IV.
Program Announcement
(PA) Number: PA-07-421
Catalog of Federal Domestic Assistance Number(s)
93.361, 93.393, 93.837
Key Dates
Release/Posted Date: July 27, 2007
Opening Date: September 5, 2007 (Earliest date an application may be submitted to Grants.gov)
Letters of Intent Receipt Date(s): Not Applicable
NOTE: On time submission requires that applications be successfully submitted to Grants.gov no later than 5:00 p.m. local time (of the applicant institution/organization).
Application Submission/Receipt Date(s): Standard dates apply, please see http://grants1.nih.gov/grants/funding/submissionschedule.htm
AIDS Application Submission/Receipt Date(s): Standard dates apply, please see http://grants1.nih.gov/grants/funding/submissionschedule.htm#AIDS.
Peer Review Date(s): Standard dates apply, please see http://grants1.nih.gov/grants/funding/submissionschedule.htm#reviewandaward
Council Review Date(s): Standard dates apply, please see http://grants1.nih.gov/grants/funding/submissionschedule.htm#reviewandaward
Earliest Anticipated Start Date(s): Standard dates apply, please see http://grants1.nih.gov/grants/funding/submissionschedule.htm#reviewandaward
Additional Information To Be Available Date (URL Activation Date): Not Applicable
Expiration Date: September 8, 2010
Due Dates for E.O. 12372
Not Applicable
Overview Content
Executive Summary
Table of Contents
Part I Overview
Part II Full Text of Announcement
Section I. Funding Opportunity Description
1. Research Objectives
Section II. Award Information
1. Mechanism of Support
2. Funds Available
Section III. Eligibility Information
1. Eligible Applicants
A. Eligible Institutions
B. Eligible Individuals
2. Cost Sharing or Matching
3. Other - Special Eligibility Criteria
Section IV. Application and Submission Information
1. Request Application Information
2. Content and Form of Application Submission
3. Submission Dates and Times
A. Submission, Review, and Anticipated Start Dates
1. Letter of Intent
B. Submitting an Application Electronically to the NIH
C. Application Processing
4. Intergovernmental Review
5. Funding Restrictions
6. Other Submission Requirements
Section V. Application Review Information
1. Criteria
2. Review and Selection Process
A. Additional Review Criteria
B. Additional Review Considerations
C. Sharing Research Data
D. Sharing Research Resources
3. Anticipated Announcement and Award Dates
Section VI. Award Administration Information
1. Award Notices
2. Administrative and National Policy Requirements
3. Reporting
Section VII. Agency Contact(s)
1. Scientific/Research Contact(s)
2. Peer Review Contact(s)
3. Financial/Grants Management Contact(s)
Section VIII. Other Information - Required Federal Citations
Part II - Full Text of Announcement
Section I. Funding Opportunity Description
1. Research Objectives
It is well documented that males experience approximately a five-year shorter life expectancy when compared with females. During the 20th century, life expectancy at birth increased from 48 to 74 years for males and from 51 to 79 years for females. Increases in life expectancy are, in part, attributed to improvements in lifestyle, nutrition, housing, hygiene and medical care. The disparities in life expectancy are more pronounced among men of color and economically disadvantaged males. For example, the life expectancy of
European American males and African American males are 74.6 and 67.7 years respectively.
In 2005, the National Center for Health Statistics reported the leading causes of death in males as heart disease, cancer (lung and prostate), accidents unintentional injuries, stroke, lung disease, diabetes, pneumonia, influenza, suicide, chronic liver disease, and Alzheimers disease. Mortality rates from these causes of death are higher for minority males because their diseases are at a more advanced stage at diagnosis and are often complicated by co-existing conditions.
To illustrate, while cardiovascular disease is the leading cause of death for all Americans, white males have the greatest mortality from cardiovascular disease, 39.2% of all deaths, followed by 36.1% of all deaths for Asian American and Pacific Islander males, and 34.2% of all deaths for African American males. While Hispanic males experience the lowest death rate from cardiovascular disease, 27.9%, they suffer disproportionately from other conditions related to heart disease namely hypertension, high cholesterol and diabetes. African American males experience an earlier onset of the disease and experience a higher rate of complications. Cardiovascular disease mortality rates in African American males ages 35-64 are more than twice those of Caucasian males. One out of six African American men, ages 30-39, has hypertension, and by age 50-59, almost 60% are hypertensive. African American men also have low hypertension control rates and higher risk of fatality from stroke when compared to their White counterparts.
Other examples of health disparities noted among minority males include the following:
Many of the disparities in health status noted among racial and ethnically diverse male populations are related to lifestyle and are either preventable or amenable to early detection or intervention. For example, tobacco use constitutes the single most preventable cause of premature death in the US. In 2004, an estimated 44.5 million adults in the United States were smokers - 23.4% of men and 18.5% of women. Cigarette smoking was highest among male Alaska Natives (33.4%), followed by African Americans (23.9%), Hispanics (18.9%), and Asian/Pacific Islanders (17.8%).
Similarly, many unintentional injuries are preventable and can be prevented
if intervention is instituted early. According to epidemiologists, Over 400 Americans die each day from unintentional injuries such as motor vehicle crashes, poisonings, drowning, falls, fires, suffocation, and firearms. A major objective outlined by Healthy People 2010 is to reduce deaths from unintentional injuries from baseline 35.0 deaths per 100,000 populations to 17.5 deaths per 100,000 populations.
Males are more likely than females to experience death from unintentional injury. Minority males are more at risk to die from such injuries when compared with their White counterparts. For example, in 2004 the death rate for unintentional injuries is 51.6 per 1000,000 deaths (year) for white males. The death rate for unintentional injuries is 51.6 per 100,000 deaths for White males. This compares with 72.5 deaths per 100,000 for American Indian/Alaska Native males followed by 55.6 per 100,000 deaths for African American males and 44.7 per 100,000 deaths for Hispanic males. The disparities in health are often more pronounced among underserved and uninsured racial and ethnic minority males who often delay in seeking clinical care. There are ample data highlighting that uninsured individuals experience greater declines in health status and die prematurely from a variety of illnesses when compared to those with continuous health care coverage. This is particularly important given that racial and ethnic minority populations are disproportionately represented among the uninsured. For example, in 2005, 23% of African American males were uninsured followed by 30.7% of Hispanic males. This compares with 11.2% White males. These and other health disparities noted among minority males require greater elucidation and intervention.
The focus of this FOA is on health promotion among racial and ethnic minority men. A scientific exploration of these disparities is central to NIHs commitment to reducing health disparities. Research in this area is essential to addressing Goal 2 outlined in Healthy People 2010: "To eliminate health disparities among segments of the population, including differences that occur by gender, race or ethnicity, education or income, disability, geographic location or sexual orientation."
The following are potential areas of research related to this announcement. These suggested areas of research are not listed in any priority and are not to be viewed as an exhaustive or exclusive list. Investigators responding to this announcement may target other groups of minority males (e.g., men of diverse sexual orientation, migrant workers, disabled men, rural and immigrant men).
Potential research topics include but are not limited to:
Section VIII, Other Information - Required Federal Citations, for policies related to this announcement.
Section II. Award Information
Mechanism of Support
This FOA will use the NIH Exploratory/Developmental Research Grant (R21) award mechanism. As an applicant, you will be solely responsible for planning, directing, and executing the proposed project.
This FOA uses just-in-time concepts. It also uses the modular as well as the non-modular budget formats (see the Modular Applications and Awards section of the NIH Grants Policy Statement. Specifically, if you are submitting an application with direct costs in each year of $250,000 or less (excluding consortium Facilities and Administrative [F&A] costs), use the PHS398 Modular Budget component provided in the SF424 (R&R) Application Package and SF424 (R&R) Application Guide (see specifically Section 3.4, Modular Budget Component, of the Application Guide).
All foreign applicants must complete and submit budget requests using the Research & Related Budget component found in the application package for this FOA. See NOT-OD-06-096, August 23, 2006.
Exploratory/developmental grant support is for new projects only; competing renewal (formerly competing continuation) applications will not be accepted. Applicants may submit a resubmission, but such application must include an Introduction addressing issues raised in the previous critique (Summary Statement).
2. Funds Available
Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. Although the financial plans of the Institutes and Centers (ICs) provide support for this program, awards pursuant to this funding opportunity are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.
total project period for an application submitted in response to this funding
opportunity may not exceed 2 years. Although the size
of award may vary with the scope of research proposed, it is expected that
applications will stay within the budgetary guidelines for an
exploratory/developmental project; direct costs are limited to $275,000 over an R21 two-year period, with no more than $200,000
in direct costs allowed in any single year. Applicants may request direct costs
in $25,000 modules, up to the total direct costs limitation of $275,000 for the
combined two-year award period. NIH grants policies
as described in the NOT-OD-05-004.
Section III. Eligibility Information
1. Eligible Applicants
1.A. Eligible Institutions
You may submit an application(s) if your institution/organization has any of the following characteristics:
1.B. Eligible Individuals
Any individual with the skills, knowledge, and resources
necessary to carry out the proposed research as the Project Director/Principal
Investigator (PD/PI) is invited to work with his/her organization to develop an
application for support. Individuals from underrepresented racial and ethnic
groups as well as individuals with disabilities are always encouraged to apply
for NIH support.
More than one PD/PI, or multiple PDs/PIs, may be designated on the application for projects that require a team science approach that clearly does not fit the single-PD/PI model. Additional information on the implementation plans and policies and procedures to formally allow more than one PD/PI on individual research projects is available at https://grants.nih.gov/grants/multi_pi. All PDs/PIs must be registered in the NIH eRA Commons prior to the submission of the application (see http://era.nih.gov/ElectronicReceipt/preparing.htm for instructions).
The decision of whether to apply for a single PD/PI or multiple PD/PI grant is the responsibility of the investigators and applicant organizations and should be determined by the scientific goals of the project. Applications for multiple PD/PI grants will require additional information, as outlined in the instructions below. When considering multiple PDs/PIs, please be aware that the structure and governance of the PD/PI leadership team as well as the knowledge, skills and experience of the individual PD/PIs will be factored into the assessment of the overall scientific merit of the application. Multiple PDs/PIs on a project share the authority and responsibility for leading and directing the project, intellectually and logistically. Each PD/PI is responsible and accountable to the grantee organization, or, as appropriate, to a collaborating organization, for the proper conduct of the project or program, including the submission of required reports. For further information on multiple PDs/PIs, please see https://grants.nih.gov/grants/multi_pi.
2. Cost Sharing or
This program does not require cost sharing as defined in the current NIH Grants Policy Statement.
3. Other-Special Eligibility Criteria
Applicants may submit more than one application, provided each application is scientifically distinct.
Section IV. Application and Submission Information
To download a SF424 (R&R) Application Package and
SF424 (R&R) Application Guide for completing the SF424 (R&R) forms for
this FOA, link to http://www.grants.gov/Apply/ and follow the directions provided on that Web site.
A one-time registration is required for institutions/organizations at both:
PD/PIs should work with their institutions/organizations to make sure they are registered in the eRA Commons.
Several additional separate actions are required before an applicant institution/organization can submit an electronic application, as follows:
1) Organizational/Institutional Registration in Grants.gov/Get Started
2) Organizational/Institutional Registration in the eRA Commons
3) Project Director/Principal Investigator (PD/PI) Registration in the NIH eRA Commons: Refer to the NIH eRA Commons System (COM) Users Guide.
Both the PD/PI and AOR/SO need separate accounts in the NIH eRA Commons since both are authorized to view the application image.
Note that if a PD/PI is also an NIH peer-reviewer with an Individual DUNS and CCR registration, that particular DUNS number and CCR registration are for the individual reviewer only. These are different than any DUNS number and CCR registration used by an applicant organization. Individual DUNS and CCR registration should be used only for the purposes of personal reimbursement and should not be used on any grant applications submitted to the Federal Government.
Several of the steps of the registration process could take four weeks or more. Therefore, applicants should immediately check with their business official to determine whether their organization/institution is already registered in both Grants.gov and the Commons. The NIH will accept electronic applications only from organizations that have completed all necessary registrations.
1. Request Application Information
Applicants must download the SF424 (R&R) application forms and SF424 (R&R) Application Guide for this FOA through Grants.gov/Apply.
Note: Only the forms package
directly attached to a specific FOA can be used. You will not be able to use
any other SF424 (R&R) forms (e.g., sample forms, forms from another FOA),
although some of the "Attachment" files may be useable for more than
one FOA.
For further assistance, contact GrantsInfo: Telephone 301-710-0267, Email: email@example.com.
Telecommunications for the hearing impaired: TTY 301-451-5936.
2. Content and Form of Application Submission
Prepare all applications using the SF424 (R&R) application forms and in accordance with the SF424 (R&R) Application Guide (MS Word or PDF).
The SF424 (R&R) Application Guide is critical to submitting a complete and accurate application to NIH. There are fields within the SF424 (R&R) application components that, although not marked as mandatory, are required by NIH (e.g., the Credential log-in field of the Research & Related Senior/Key Person Profile component must contain the PD/PIs assigned eRA Commons User ID). Agency-specific instructions for such fields are clearly identified in the Application Guide. For additional information, see Tips and Tools for Navigating Electronic Submission on the front page of Electronic Submission of Grant Applications.
The SF424 (R&R) application is comprised of data arranged in separate components. Some components are required, others are optional. The forms package associated with this FOA in Grants.gov/APPLY will include all applicable components, required and optional. A completed application in response to this FOA will include the following components:
SF424 (R&R) (Cover component)
Research & Related Project/Performance Site Locations
Research & Related Other Project Information
Research & Related Senior/Key Person
PHS398 Modular Budget
PHS398 Cover Page Supplement
PHS398 Research Plan
PHS398 Checklist
PHS398 Modular Budget or Research & Related Budget, as appropriate (See Section IV.6., Special Instructions, regarding appropriate required budget component.)
Research & Related Budget (required for foreign applications)
Optional Components:
PHS398 Cover Letter File
Research & Related Subaward Budget Attachment(s) Form
Foreign Organizations
Several special provisions apply to applications submitted by foreign organizations:
Proposed research should provide special opportunities for furthering research programs through the use of unusual talent, resources, populations, or environmental conditions in other countries that are not readily available in the United States or that augment existing U.S. resources.
Applications with Multiple PDs/PIs
When multiple PDs/PIs are proposed, NIH requires one PD/PI to be designated as the "Contact PI, who will be responsible for all communication between the PDs/PIs and the NIH, for assembling the application materials outlined below, and for coordinating progress reports for the project. The contact PD/PI must meet all eligibility requirements for PD/PI status in the same way as other PDs/PIs, but has no other special roles or responsibilities within the project team beyond those mentioned above.
Information for the Contact PD/PI should be entered in Item 13 of the SF424(R&R) Cover component.All other PDs/PIs should be listed in the Research & Related Senior/Key Person component and assigned the project role of PD/PI.Please remember that all PDs/PIs must be registered in the eRA Commons prior to application submission.The Commons ID of each PD/PI must be included in the Credential field of the Research & Related Senior/Key Person component.Failure to include this data field will cause the application to be rejected.
All projects proposing Multiple PDs/PIs will be required to include a new section describing the leadership of the project.
Multiple PD/PI Leadership Plan: For applications designating multiple PDs/PIs, a new section of the research plan, entitled Multiple PD/PI Leadership Plan, must be included. A rationale for choosing a multiple PD/PI approach should be described. The governance and organizational structure of the leadership team and the research project should be described, including communication plans, process for making decisions on scientific direction, and procedures for resolving conflicts.The roles and administrative, technical, and scientific responsibilities for the project or program should be delineated for the PDs/PIs and other collaborators.
If budget allocation is planned, the distribution of resources to specific components of the project or the individual PDs/PIs should be delineated in the Leadership Plan. In the event of an award, the requested allocations may be reflected in a footnote on the Notice of Award.
Applications Involving a Single Institution
When all PDs/PIs are within a single institution, follow the instructions contained in the SF424 (R&R) Application Guide.
Applications Involving Multiple Institutions
When multiple institutions are involved, one institution must be designated as the prime institution and funding for the other institution(s) must be requested via a subcontract to be administered by the prime institution. When submitting a detailed budget, the prime institution should submit its budget using the Research & Related Budget component.All other institutions should have their individual budgets attached separately to the Research & Related Subaward Budget Attachment(s) Form.See Section 4.8 of the SF424 (R&R) Application Guide for further instruction regarding the use of the subaward budget form.
When submitting a modular budget, the prime institution completes the PHS398 Modular Budget component only.Information concerning the consortium/subcontract budget is provided in the budget justification. Separate budgets for each consortium/subcontract grantee are not required when using the Modular budget format. See Section 3.4 of the Application Guide for further instruction regarding the use of the PHS398 Modular Budget component.
3. Submission Dates and Times
See Section IV.3.A for details.
3.A. Submission, Review, and Anticipated Start Dates
Opening Date:September 5, 2007 (Earliest date an application may be submitted to Grants.gov)
Letters of Intent Receipt Date(s): Not Applicable.
Application Submission Date(s): Standard dates apply, please see https://grants.nih.gov/grants/funding/submissionschedule.htm
AIDS Application Submission Date(s): Standard dates apply, please see http://grants1.nih.gov/grants/funding/submissionschedule.htm#AIDS
Peer Review Date(s): Standard dates apply, please see http://grants1.nih.gov/grants/funding/submissionschedule.htm#reviewandaward
Council Review Date(s): Standard dates apply, please see http://grants1.nih.gov/grants/funding/submissionschedule.htm#reviewandaward
Earliest Anticipated Start Date: Standard dates apply, please see http://grants1.nih.gov/grants/funding/submissionschedule.htm#reviewandaward
3.A.1. Letter of Intent
A letter of intent is not required for the funding opportunity.
3.B. Submitting an Application Electronically to the
To submit an application in response to this FOA, applicants should access this FOA via http://www.grants.gov/Apply and follow steps 1-4. Note: Applications must only be submitted electronically. PAPER APPLICATIONS WILL NOT BE ACCEPTED.
3.C. Application Processing
Applications may be submitted on or after the opening date and must be successfully received by Grants.gov no later than 5:00 p.m. local time(of the applicant institution/organization) on the application submission/receipt date(s). (See Section IV.3.A. for all dates.) If an application is not submitted by the receipt date(s) and time, the application may be delayed in the review process or not reviewed.
Once an application package has been successfully submitted through Grants.gov, any errors have been addressed, and the assembled application has been created in the eRA Commons, the PD/PI and the Authorized Organization Representative/Signing Official (AOR/SO) have two business days to view the application image.
Upon receipt, applications will
be evaluated for completeness by the Center for Scientific Review, NIH.
Incomplete applications will not be reviewed.
There will be an acknowledgement of receipt of applications from Grants.gov and the Commons. Information related to the assignment of an application to a Scientific Review Group is also in the Commons.
The NIH will not accept any application in response to this FOA that is essentially the same as one currently pending initial merit review unless the applicant withdraws the pending application. The NIH will not accept any application that is essentially the same as one already reviewed. This does not preclude the submission of an application already reviewed with substantial changes, but such application must include an Introduction addressing the previous critique. Note such an application is considered a "resubmission" for the SF424 (R&R).
4. Intergovernmental Review
This initiative is not subject to intergovernmental review.
5. Funding Restrictions
All NIH awards are subject to the terms and conditions, cost principles, and other considerations described in the NIH Grants Policy Statement.
Pre-award costs are allowable. A grantee may, at its own risk and without NIH prior approval, incur obligations and expenditures to cover costs up to 90 days before the beginning date of the initial budget period of a new award if such costs: are necessary to conduct the project, and would be allowable under the grant, if awarded, without NIH prior approval. If specific expenditures would otherwise require prior approval, the grantee must obtain NIH approval before incurring the cost. NIH prior approval is required for any costs to be incurred more than 90 days before the beginning date of the initial budget period of a new award.
The incurrence of pre-award costs in anticipation of a competing or non-competing award imposes no obligation on NIH either to make the award or to increase the amount of the approved budget if an award is made for less than the amount anticipated and is inadequate to cover the pre-award costs incurred. NIH expects the grantee to be fully aware that pre-award costs result in borrowing against future support and that such borrowing must not impair the grantee's ability to accomplish the project objectives in the approved time frame or in any way adversely affect the conduct of the project. See the NIH Grants Policy Statement.
6. Other Submission Requirements
PD/PI Credential (e.g., Agency Login)
The NIH requires the PD/PI to fill in his/her Commons User ID in the PROFILE Project Director/Principal Investigator section, Credential log-in field of the Research & Related Senior/Key Person Profile component. The applicant organization must include its DUNS number in its Organization Profile in the eRA Commons. This DUNS number must match the DUNS number provided at CCR registration with Grants.gov. For additional information, see Tips and Tools for Navigating Electronic Submission on the front page of Electronic Submission of Grant Applications.
Organizational DUNS
The applicant organization must include its DUNS number in its Organization Profile in the eRA Commons. This DUNS number must match the DUNS number provided at CCR registration with Grants.gov. For additional information, see Frequently Asked Questions Application Guide, Electronic Submission of Grant Applications.
Warning: Please be sure that you observe the direct cost, project period, and page number limitations specified above for this FOA. Application processing may be delayed or the application may be rejected if it does not comply with these requirements.
PHS398 Research Plan Component Sections
While each section of the Research Plan needs to be uploaded separately as a PDF attachment, applicants are encouraged to construct the Research Plan component as a single document, separating sections into distinct PDF attachments just before uploading the files. This approach will enable applicants to better monitor formatting requirements such as page limits. All attachments must be provided to NIH in PDF format, filenames must be included with no spaces or special characters, and a .pdf extension must be used.
All application instructions outlined in the SF424 (R&R) Application Guide (MS Word or PDF) are to be followed, incorporating "Just-in-Time" information concepts, and with the following requirements for R21 applications:
Appendix Materials
has published new limitations on grant application appendix materials to
encourage applications to be as concise as possible while containing the
information needed for expert scientific review. See https://grants.nih.gov/grants/guide/notice-files/NOT-OD-07-018.html
Applicants must follow the specific instructions on Appendix materials as described in the SF424 (R&R) Application Guide (See https://grants.nih.gov/grants/funding/424/index.htm).
Do not use the Appendix to circumvent the page limitations. An application that does not observe these limitations may be delayed in the review process.
Note: While each section of the PHS398 Research Plan component needs to be uploaded separately as a PDF attachment, applicants are encouraged to construct the Research Plan component as a single document, separating sections into distinct PDF attachments just before uploading the files. This approach will enable applicants to monitor better formatting requirements such as page limits. All attachments must be provided to NIH in PDF format, filenames must be included with no spaces or special characters, and a .pdf extension must be used.
Foreign Applications (Non-domestic (non-U.S.) Entity)
for Sharing Research Data
The precise content of the data-sharing plan will vary, depending on the data being collected and how the investigator is planning to share the data. Applicants who are planning to share data may wish to describe briefly the expected schedule for data sharing, the format of the final dataset, the documentation to be provided, whether or not any analytic tools also will be provided, whether or not a data-sharing agreement will be required and, if so, a brief description of such an agreement (including the criteria for deciding who can receive the data and whether or not any conditions will be placed on their use), and the mode of data sharing (e.g., under their own auspices by mailing a disk or posting data on their institutional or personal website, through a data archive or enclave). Investigators choosing to share under their own auspices may wish to enter into a data-sharing agreement. References to data sharing may also be appropriate in other sections of the application.
All applicants must include a plan for sharing research data in their application. The data sharing policy is available at https://grants.nih.gov/grants/policy/data_sharing. All investigators responding to this funding opportunity should include a description of how final research data will be shared, or explain why data sharing is not possible.
The reasonableness of the data sharing plan or the rationale for not sharing research data will be assessed by the reviewers. However, reviewers will not factor the proposed data sharing plan into the determination of scientific merit or the impact/priority score.
Sharing Research Resources
policy expects
s that grant recipients make unique
research resources readily available for research purposes to qualified
individuals within the scientific community after publication (See the NIH Grants Policy Statement https://grants.nih.gov/archive/grants/policy/nihgps_2003/index.htm#_Toc54600131).
Investigators responding to this funding opportunity should include a sharing
research resources plan addressing how unique research resources will be shared
or explain why sharing is not possible.
The adequacy of the resources sharing plan and any related data sharing plans will be considered by Program staff of the funding organization when making recommendations about funding applications. The effectiveness of the resource sharing will be evaluated as part of the administrative review of each Non-Competing Grant Progress Report (PHS 2590). See Section VI.3., Reporting.
Section V. Application Review Information
1. Criteria (Update: Enhanced review criteria have been issued for the evaluation of research applications received for potential FY2010 funding and thereafter - see NOT-OD-09-025).
Only the review criteria described below will be
considered in the review process.
2. Review and Selection Process
Applications submitted for this funding opportunity will be assigned to the ICs on the basis of established PHS referral guidelines.
Appropriate scientific review groups convened in accordance with the standard NIH peer review procedures (http://www.csr.nih.gov/refrev.htm) will evaluate applications for scientific and technical merit.
As part of the initial merit review, all applications will:
Applications submitted in response to this funding opportunity will compete for available funds with all other recommended applications. The following will be considered in making funding decisions:
The NIH R21 exploratory/developmental grant is a mechanism for supporting novel scientific ideas or new model systems, tools, or technologies that have the potential to significantly advance our knowledge or the status of health-related research. Because the Research Strategy is limited to 6 pages, an exploratory/developmental grant application need not have extensive background material or preliminary information as one might normally expect in an R01 application. Accordingly, reviewers will focus their evaluation on the conceptual framework, the level of innovation, and the potential to significantly advance our knowledge or understanding. Reviewers will place less emphasis on methodological details and certain indicators traditionally used in evaluating the scientific merit of R01 applications, including supportive preliminary data. Appropriate justification for the proposed work can be provided through literature citations, data from other sources, or, when available, from investigator-generated data. Preliminary data are not required for R21 applications; however, they may be included if available.
The goals of NIH supported research are to advance our understanding of biological systems, to improve the control of disease, and to enhance health. In their written critiques, reviewers will be asked to comment on each of the following criteria in order to judge the likelihood that the proposed research will have a substantial impact on the pursuit of these goals. Each of these criteria will be addressed and considered in assigning the overall score, weighting them as appropriate for each application.
Note that an application does not
need to be strong in all categories to be judged likely to have major
scientific impact and thus deserve a high impact/priority score. For example, an
investigator may propose to carry out important work that by its nature is not
innovative but is essential to move a field forward.
Overall Impact. Reviewers will provide an overall impact/priority score to reflect their assessment of the likelihood for the project to exert a sustained, powerful influence on the research field(s) involved, in consideration of the following five core review criteria, and additional review criteria (as applicable for the project proposed).
Core Review Criteria. Reviewers will consider each of the five review criteria below in the determination of scientific and technical merit, and give a separate score for each. An application does not need to be strong in all categories to be judged likely to have major scientific impact. For example, a project that by its nature is not innovative may be essential to advance a field.
Significance: Does the project address an important problem or a critical barrier to progress in the field? If the aims of the project are achieved, how will scientific knowledge, technical capability, and/or clinical practice be improved? How will successful completion of the aims change the concepts, methods, technologies, treatments, services, or preventative interventions that drive this field?
Investigator(s): Are the investigators appropriately trained and well suited to carry out this work? Is the work proposed appropriate to the experience level of the PD/PI and other researchers? Does the investigative team bring complementary and integrated expertise to the project (if applicable)?
Innovation: Does the application challenge and seek to shift current research or clinical practice paradigms by utilizing novel theoretical concepts, approaches or methodologies, instrumentation, or interventions? Are the concepts, approaches or methodologies, instrumentation, or interventions novel to one field of research or novel in a broad sense? Is a refinement, improvement, or new application of theoretical concepts, approaches or methodologies, instrumentation, or interventions proposed?
Approach: Are the overall strategy, methodology, and analyses well-reasoned and appropriate to accomplish the specific aims of the project? Are potential problems, alternative strategies, and benchmarks for success presented? If the project is in the early stages of development, will the strategy establish feasibility and will particularly risky aspects be managed?
If the project involves clinical research, are the plans for 1) protection of human subjects from research risks, and 2) inclusion of minorities and members of both sexes/genders, as well as the inclusion of children, justified in terms of the scientific goals and research strategy proposed?
Environment: Does the scientific environment in which the work will be done contribute to the probability of success? Do the proposed studies benefit from unique features of the scientific environment, or subject populations, or employ useful collaborative arrangements? Is there evidence of institutional support?
Additional Review Criteria
As applicable for the project proposed, reviewers will consider the following additional items in the determination of scientific and technical merit, but will not give separate scores for these items.
Protections for Human Subjects. For research that involves human subjects but does not involve one of the six categories of research that are exempt under 45 CFR Part 46, the committee will evaluate the justification for involvement of human subjects and the proposed protections from research risk relating to their participation according to the following five review criteria: 1) risk to subjects, 2) adequacy of protection against risks, 3) potential benefits to the subjects and others, 4) importance of the knowledge to be gained, and 5) data and safety monitoring for clinical trials.
For research that involves human subjects and meets the criteria for one or more of the six categories of research that are exempt under 45 CFR Part 46, the committee will evaluate: 1) the justification for the exemption, 2) human subjects involvement and characteristics, and 3) sources of materials.
Inclusion of Women, Minorities, and Children. When the proposed project involves clinical research, the committee will evaluate the proposed plans for inclusion of minorities and members of both genders, as well as the inclusion of children.
Vertebrate Animals. The committee will evaluate the involvement of live vertebrate animals as part of the scientific assessment according to the following five points: 1) proposed use of the animals, and species, strains, ages, sex, and numbers to be used; 2) justifications for the use of animals and for the appropriateness of the species and numbers proposed; 3) adequacy of veterinary care; 4) procedures for limiting discomfort, distress, pain and injury to that which is unavoidable in the conduct of scientifically sound research including the use of analgesic, anesthetic, and tranquilizing drugs and/or comfortable restraining devices; and 5) methods of euthanasia and reason for selection if not consistent with the AVMA Guidelines on Euthanasia.
Resubmission Applications. When reviewing a Resubmission application (formerly called an amended application), the committee will evaluate the application as now presented, taking into consideration the responses to comments from the previous scientific review group and changes made to the project.
Renewal Applications. When reviewing a Renewal application (formerly called a competing continuation application), the committee will consider the progress made in the last funding period.
Revision Applications. When reviewing a Revision application (formerly called a competing supplement application), the committee will consider the appropriateness of the proposed expansion of the scope of the project. If the Revision application relates to a specific line of investigation presented in the original application that was not recommended for approval by the committee, then the committee will consider whether the responses to comments from the previous scientific review group are adequate and whether substantial changes are clearly evident.
Biohazards. Reviewers will assess whether materials or procedures proposed are potentially hazardous to research personnel and/or the environment, and if needed, determine whether adequate protection is proposed.
Additional Review Considerations
As applicable for the project proposed, reviewers will address each of the following items, but will not give scores for these items and should not consider them in providing an overall impact score.
Budget and Period Support. Reviewers will consider whether the budget and the requested period of support are fully justified and reasonable in relation to the proposed research.
Select Agents Research. Reviewers will assess the information provided in this section of the application, including 1) the Select Agent(s) to be used in the proposed research, 2) the registration status of all entities where Select Agent(s) will be used, 3) the procedures that will be used to monitor possession use and transfer of Select Agent(s), and 4) plans for appropriate biosafety, biocontainment, and security of the Select Agent(s).
Applications from Foreign Organizations. Reviewers will assess whether the project presents special opportunities for furthering research programs through the use of unusual talent, resources, populations, or environmental conditions that exist in other countries and either are not readily available in the United States or augment existing U.S. resources.
Resource Sharing Plans. Reviewers will comment on whether the following Resource Sharing Plans, or the rationale for not sharing the following types of resources, are reasonable: 1) Data Sharing Plan (https://grants.nih.gov/grants/policy/data_sharing/data_sharing_guidance.htm); 2) Sharing Model Organisms (https://grants.nih.gov/grants/guide/notice-files/NOT-OD-04-042.html); and 3) Genome Wide Association Studies (GWAS) (https://grants.nih.gov/grants/guide/notice-files/NOT-OD-07-088.html).
Sharing Research Data
Data Sharing Plan: The reasonableness of the data sharing plan or the rationale for not sharing research data may be assessed by the reviewers. However, reviewers will not factor the proposed data sharing plan into the determination of scientific merit or the impact/priority score. The funding organization will be responsible for monitoring the data sharing policy. https://grants.nih.gov/grants/policy/data_sharing.
2.D. Sharing Research Resources
NIH policy expects that grant recipients make unique research resources readily available for research purposes to qualified individuals within the scientific community after publication (See the NIH Grants Policy Statement https://grants.nih.gov/archive/grants/policy/nihgps_2003/index.htm#_Toc54600131). Investigators responding to this funding opportunity should include a sharing research resources plan addressing how unique research resources will be shared or explain why sharing is not possible.
Program staff will be responsible for the administrative review of the plan for sharing research resources.
The adequacy of the resources
sharing plan and any related data sharing plans will be considered by Program
staff of the funding organization when making recommendations about funding
applications. The effectiveness of the resource sharing will be evaluated as
part of the administrative review of each Non-Competing Grant
Progress Report (PHS 2590), See Section VI.3.,
Model Organism Sharing Plan: Reviewers are asked to assess the sharing plan in an administrative note. The sharing plan itself should be discussed after the application is scored. Whether a sharing plan is reasonable can be determined by the reviewers on a case-by-case basis, taking into consideration the organism, the timeline, the applicant's decision to distribute the resource or deposit it in a repository, and other relevant considerations. For the R21 mechanism, the presence or adequacy of a plan should not enter into the scoring of the application.
3. Anticipated
Announcement and Award Dates
Not Applicable
Section VI. Award Administration Information
Award Notices
After the peer review of the application is completed, the PD/PI will be able to access his or her Summary Statement (written critique) via the NIH eRA Commons.
If the application is under
consideration for funding, NIH will request "just-in-time"
information from the applicant. For details, applicants may refer to the NIH
Grants Policy Statement Part II: Terms and Conditions of NIH Grant Awards,
Subpart A: General.
A formal notification in the form of a Notice of Award (NoA) will be provided to the applicant organization. The NoA signed by the grants management officer is the authorizing document. Once all administrative and programmatic issues have been resolved, the NoA will be generated via email notification from the awarding component to the grantee business official.
Selection of an application for award is not an authorization to begin performance. Any costs incurred before receipt of the NoA are at the recipient's risk. These costs may be reimbursed only to the extent considered allowable pre-award costs. See Section IV.5., Funding Restrictions.
2. Administrative and National Policy Requirements
All NIH grant and cooperative agreement awards include the NIH Grants Policy Statement as part of the NoA. For these terms of award, see the NIH Grants Policy Statement Part II: Terms and Conditions of NIH Grant Awards, Subpart A: General and Part II: Terms and Conditions of NIH Grant Awards, Subpart B: Terms and Conditions for Specific Types of Grants, Grantees, and Activities.
When multiple years are involved, awardees will be required to submit the Non-Competing Grant Progress Report (PHS 2590) annually and financial statements as required in the NIH Grants Policy Statement.
We encourage your inquiries
concerning this funding opportunity and welcome the opportunity to answer
questions from potential applicants. Inquiries may fall into three areas:
scientific/research, peer review, and financial or grants management issues:
1. Scientific/Research Contacts:
Dr. Paul Cotton
Program Director
Office of Extramural Programs
NIH, National Institute of Nursing Research
6701 Democracy Blvd, Room 710, MSC 4870
Bethesda, MD 20892-4870
Telephone: (301) 402-6423
Fax: (301) 480-8260
Email: email@example.com
Dr. Charlotte
Program Director
Division of Prevention and Population Sciences
NIH, National Heart, Lung and Blood Institute
6701 Rockledge Drive, Suite 10118, MSC 7936
Bethesda, MD 20892-7936
Telephone: (301) 435-0382
Fax: (301) 480-5158
E-mail: email@example.com
Dr. Linda
Chief, Health Promotion Research Branch
Behavioral Research Program
Division of Cancer Control and Population Sciences
NIH, National Cancer Institute
6130 Executive Blvd., Room 4060
Rockville, MD 20892
Phone: 301-435-2841
Fax: 301-435-7547
E-mail: email@example.com
Dr. Lawrence J.
Medical Advisor
NIH, Office of Behavioral and Social Sciences Research
Building One, Room 256
One Center Drive
Bethesda, MD 20892
Telephone: (301) 435-6780
Fax: (301) 402-1150
Email: email@example.com
2. Peer Review Contacts:
Not Applicable
3. Financial or Grants Management Contacts:
Brian Albertini
Chief, Office of Grants and Contract Management
NIH, National Institute of Nursing Research
6701 Democracy Blvd., Suite 710
Bethesda, MD 20892
Telephone: (301) 594-6869
Fax: (301) 451-5648
Email: firstname.lastname@example.com
Section VIII. Other Information
Required Federal Citations
Vertebrate Animals:
Recipients of PHS support for activities involving live, vertebrate animals must comply with PHS Policy on Humane Care and Use of Laboratory Animals (https://grants.nih.gov/grants/olaw/references/PHSPolicyLabAnimals.pdf) as mandated by the Health Research Extension Act of 1985 (https://grants.nih.gov/grants/olaw/references/hrea1985.htm), and the USDA Animal Welfare Regulations (http://www.nal.usda.gov/awic/legislat/usdaleg1.htm) as applicable.
Human Subjects Protection:
Federal regulations (45 CFR 46) require that applications and proposals involving human subjects must be evaluated with reference to the risks to the subjects, the adequacy of protection against these risks, the potential benefits of the research to the subjects and others, and the importance of the knowledge gained or to be gained (http://www.hhs.gov/ohrp/humansubjects/guidance/45cfr46.htm).
Data and Safety Monitoring Plan:
Data and safety monitoring is required for all types of clinical trials, including physiologic toxicity and dose-finding studies (phase I); efficacy studies (Phase II); efficacy, effectiveness and comparative trials (Phase III). Monitoring should be commensurate with risk. The establishment of data and safety monitoring boards (DSMBs) is required for multi-site clinical trials involving interventions that entail potential risks to the participants (NIH Policy for Data and Safety Monitoring, NIH Guide for Grants and Contracts, https://grants.nih.gov/grants/guide/notice-files/not98-084.html).
Sharing Research Data:
Investigators submitting an NIH application seeking $500,000 or more in direct costs in any single year are expected to include a plan for data sharing or state why this is not possible (https://grants.nih.gov/grants/policy/data_sharing).
Investigators should seek guidance from their institutions, on issues related to institutional policies and local IRB rules, as well as local, State and Federal laws and regulations, including the Privacy Rule. Reviewers will consider the data sharing plan but will not factor the plan into the determination of the scientific merit or the impact/priority score.
Access to Research
Data through the Freedom of Information Act:
The Office of Management and Budget (OMB) Circular A-110 has been revised to provide access to research data through the Freedom of Information Act (FOIA) under some circumstances. Data that are (1) first produced in a project that is supported in whole or in part with Federal funds and (2) cited publicly and officially by a Federal agency in support of an action that has the force and effect of law (i.e., a regulation) may be accessed through FOIA. It is important for applicants to understand the basic scope of this amendment. NIH has provided guidance at https://grants.nih.gov/grants/policy/a110/a110_guidance_dec1999.htm. Applicants may wish to place data collected under this funding opportunity in a public archive, which can provide protections for the data and manage the distribution for an indefinite period of time. If so, the application should include a description of the archiving plan in the study design and include information about this in the budget justification section of the application. In addition, applicants should think about how to structure informed consent statements and other human subjects procedures given the potential for wider use of data collected under this award.
Sharing of Model Organisms:
NIH is committed to support efforts that encourage sharing of important research resources including the sharing of model organisms for biomedical research (see https://grants.nih.gov/grants/policy/model_organism/index.htm). At the same time the NIH recognizes the rights of grantees and contractors to elect and retain title to subject inventions developed with Federal funding pursuant to the Bayh Dole Act (see the NIH Grants Policy Statement). Beginning October 1, 2004, all investigators submitting an NIH application or contract proposal are expected to include in the application/proposal a description of a specific plan for sharing and distributing unique model organism research resources generated using NIH funding or state why such sharing is restricted or not possible. This will permit other researchers to benefit from the resources developed with public funding. The inclusion of a model organism sharing plan is not subject to a cost threshold in any year and is expected to be included in all applications where the development of model organisms is anticipated.
Inclusion of Women, Minorities, and Children:
It is the policy of the NIH that women and members of minority groups and their sub-populations must be included in all NIH-supported clinical research projects unless a clear and compelling justification is provided indicating that inclusion is inappropriate with respect to the health of the subjects or the purpose of the research. This policy results from the NIH Revitalization Act of 1993 (Section 492B of Public Law 103-43). All investigators proposing clinical research should read the "NIH Guidelines for Inclusion of Women and Minorities as Subjects in Clinical Research (https://grants.nih.gov/grants/guide/notice-files/NOT-OD-02-001.html); a complete copy of the updated Guidelines is available at https://grants.nih.gov/grants/funding/women_min/guidelines_amended_10_2001.htm. The amended policy incorporates: the use of an NIH definition of clinical research; updated racial and ethnic categories in compliance with the new OMB standards; clarification of language governing NIH-defined Phase III clinical trials consistent with the SF424 (R&R) application; and updated roles and responsibilities of NIH staff and the extramural community. The policy continues to require for all NIH-defined Phase III clinical trials that: a) all applications or proposals and/or protocols must provide a description of plans to conduct analyses, as appropriate, to address differences by sex/gender and/or racial/ethnic groups, including subgroups if applicable; and b) investigators must report annual accrual and progress in conducting analyses, as appropriate, by sex/gender and/or racial/ethnic group differences.
Inclusion of Children as Participants in Clinical Research:
The NIH maintains a policy that children (i.e., individuals under the age of 21) must be included in all clinical research, conducted or supported by the NIH, unless there are scientific and ethical reasons not to include them.
All investigators proposing research involving human subjects should read the "NIH Policy and Guidelines" on the inclusion of children as participants in research involving human subjects (https://grants.nih.gov/grants/funding/children/children.htm).
Required Education on the Protection of Human Subject Participants:
NIH policy requires education on the protection of human subject participants for all investigators submitting NIH applications for research involving human subjects and individuals designated as key personnel. The policy is available at https://grants.nih.gov/grants/guide/notice-files/NOT-OD-00-039.html.
Human Embryonic Stem Cells (hESC):
Criteria for federal funding of research on hESCs can be found at http://stemcells.nih.gov/index.asp and at https://grants.nih.gov/grants/guide/notice-files/NOT-OD-09-116.html. Only research using hESC lines that are registered in the NIH Human Embryonic Stem Cell Registry will be eligible for Federal funding (http://escr.nih.gov). It is the responsibility of the applicant to provide in the project description and elsewhere in the application as appropriate, the official NIH identifier(s) for the hESC line(s) to be used in the proposed research.
NIH Public Access Policy:
NIH-funded investigators are requested to submit to the NIH manuscript submission (NIHMS) system (http://www.nihms.nih.gov) at PubMed Central (PMC) an electronic version of the author's final manuscript upon acceptance for publication, resulting from research supported in whole or in part with direct costs from NIH. The author's final manuscript is defined as the final version accepted for journal publication, and includes all modifications from the publishing peer review process.
NIH is requesting that authors submit manuscripts resulting from 1) currently funded NIH research projects or 2) previously supported NIH research projects if they are accepted for publication on or after May 2, 2005. The NIH Public Access Policy applies to all research grant and career development award mechanisms, cooperative agreements, contracts, Institutional and Individual Ruth L. Kirschstein National Research Service Awards, as well as NIH intramural research studies. The Policy applies to peer-reviewed, original research publications that have been supported in whole or in part with direct costs from NIH, but it does not apply to book chapters, editorials, reviews, or conference proceedings. Publications resulting from non-NIH-supported research projects should not be submitted.
For more information about the Policy or the submission process, please visit the NIH Public Access Policy Web site at http://publicaccess.nih.gov/ and view the Policy or other Resources and Tools, including the Authors' Manual.
Standards for Privacy of Individually Identifiable Health Information:
The Department of Health and Human Services (DHHS) issued final modification to the "Standards for Privacy of Individually Identifiable Health Information", the "Privacy Rule", on August 14, 2002. The Privacy Rule is a federal regulation under the Health Insurance Portability and Accountability Act (HIPAA) of 1996 that governs the protection of individually identifiable health information, and is administered and enforced by the DHHS Office for Civil Rights (OCR).
Decisions about applicability and implementation of the Privacy Rule reside with the researcher and his/her institution. The OCR website (http://www.hhs.gov/ocr/) provides information on the Privacy Rule, including a complete Regulation Text and a set of decision tools on "Am I a covered entity?" Information on the impact of the HIPAA Privacy Rule on NIH processes involving the review, funding, and progress monitoring of grants, cooperative agreements, and research contracts can be found at https://grants.nih.gov/grants/guide/notice-files/NOT-OD-03-025.html.
URLs in NIH Grant Applications or Appendices:
All applications and proposals for NIH funding must be self-contained within specified page limitations. Unless otherwise specified in an NIH solicitation, Internet addresses (URLs) should not be used to provide information necessary to the review because reviewers are under no obligation to view the Internet sites. Furthermore, we caution reviewers that their anonymity may be compromised when they directly access an Internet site.
Healthy People 2010:
The Public Health Service (PHS) is committed to achieving the health promotion and disease prevention objectives of "Healthy People 2010," a PHS-led national activity for setting priority areas. This FOA is related to one or more of the priority areas. Potential applicants may obtain a copy of "Healthy People 2010" at http://www.health.gov/healthypeople.
Authority and Regulations:
This program is described in the Catalog of Federal Domestic Assistance and is not subject to the intergovernmental review requirements of Executive Order 12372 or Health Systems Agency review. Awards are made under the authorization of Sections 301 and 405 of the Public Health Service Act as amended (42 USC 241 and 284) and under Federal Regulations 42 CFR Part 52 and 45 CFR Parts 74 and 92. All awards are subject to the terms and conditions, cost principles, and other considerations described in the NIH Grants Policy Statement.
The PHS strongly encourages all grant recipients to provide a smoke-free workplace and discourage the use of all tobacco products. In addition, Public Law 103-227, the Pro-Children Act of 1994, prohibits smoking in certain facilities (or in some cases, any portion of a facility) in which regular or routine education, library, day care, health care, or early childhood development services are provided to children. This is consistent with the PHS mission to protect and advance the physical and mental health of the American people.
Loan Repayment Programs:
NIH encourages applications for educational loan repayment from qualified health professionals who have made a commitment to pursue a research career involving clinical, pediatric, contraception, infertility, and health disparities related areas. The LRP is an important component of NIH's efforts to recruit and retain the next generation of researchers by providing the means for developing a research career unfettered by the burden of student loan debt. Note that an NIH grant is not required for eligibility and concurrent career award and LRP applications are encouraged. The periods of career award and LRP award may overlap providing the LRP recipient with the required commitment of time and effort, as LRP awardees must commit at least 50% of their time (at least 20 hours per week based on a 40 hour week) for two years to the research. For further information, please see: http://www.lrp.nih.gov.
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices
Office of Extramural
Research (OER)
National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892
Department of Health
and Human Services (HHS)
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.


text:
Finance Advisory Committee 7:30 pm
Finance Advisory Committee @ Borough Hall
May 1 @ 7:30 pm
... continue reading.
Zoning Board Meeting 7:30 pm
Zoning Board Meeting @ Borough Hall
May 2 @ 7:30 pm
... continue reading.
Green Team Meeting 10:30 am
Green Team Meeting @ DPW Building Conference Room
May 3 @ 10:30 am
... continue reading.
Mountain Lakes Volunteer Fire Department Open House 11:00 am
Mountain Lakes Volunteer Fire Department Open House @ MLVFD
May 4 @ 11:00 am – 2:00 pm
The Mountain Lakes Volunteer Fire Department will be hosting an open house on Saturday May 4th from 11:00 AM-2:00 PM. Refreshments will be served and there will be activities for the kids. There will also be a vehicle extrication demonstration at 12:30 PM. The members of the department are your friends and neighbors and your support is greatly appreciated!... continue reading.
ML Board of Education Meeting 6:30 pm
ML Board of Education Meeting @ ML High School
May 6 @ 6:30 pm
... continue reading.
Lakes Management Advisory Mtg 7:30 pm
Lakes Management Advisory Mtg @ Zoom
May 7 @ 7:30 pm
Join Zoom Meeting https://us06web.zoom.us/j/99304626096?pwd=NDk2TzVMUlJIc2w1TUt6MWlkT2RvQT09 Meeting ID: 993 0462 6096 Passcode: pzF9Jz One tap mobile +13017158592,,99304626096#,,,,*755104# US (Washington DC) +13126266799,,99304626096#,,,,*755104# US (Chicago) Dial by your location +1 301 715 8592 US (Washington DC) +1 312 626 6799 US (Chicago) +1 929 205 6099 US (New York) +1 253 215 8782 US (Tacoma) +1 346 248 7799 US (Houston) +1 669 900 6833 US (San Jose) Meeting ID: 993 0462 6096 Passcode: 755104 Find your local number: https://us06web.zoom.us/u/kbTcdJ5wfo ... continue reading.
Memorial Day Committee 7:30 pm
Memorial Day Committee @ Borough Hall
May 7 @ 7:30 pm
... continue reading.
Affordable Housing Advisory Committee 8:30 am
Affordable Housing Advisory Committee
May 8 @ 8:30 am
... continue reading.
Shade Tree Commission Meeting 7:00 pm
Shade Tree Commission Meeting @ Zoom
May 8 @ 7:00 pm – 8:00 pm
... continue reading.
Plant Sale 8:00 am
Plant Sale @ Island Beach
May 11 @ 8:00 am – 11:00 am
The Garden Club of Mountain Lakes will be holding a plant sale on Saturday, May 11th (rain or shine) from 8-11am at Island Beach. Locally-grown perennials and native plants Shop early—these plants go fast … Coffee and fresh baked goods in our Garden Café Fresh flower bouquets for Mother's Day ML Library Makerspace kids' 'Interactive Mural' For more information, contact Janet Horst at email@example.com... continue reading.
Council Meeting 7:30 pm
Council Meeting @ Borough Hall
May 13 @ 7:30 pm
Borough Council meeting... continue reading.
Woodland Advisory Committee Meeting 7:30 pm
Woodland Advisory Committee Meeting @ Borough Hall
May 15 @ 7:30 pm
Monthly meeting of the Mountain Lakes Woodlands Advisory Committee... continue reading.
Laker 55 Speaker 12:45 pm
Laker 55 Speaker @ ML Library
May 17 @ 12:45 pm – 1:45 pm
Please join us for a demonstration and discussion of art and portraiture by local artist Laurie Harden.... continue reading.
Economic Development Advisory Committee Meeting 11:00 am
Economic Development Advisory Committee Meeting @ Borough Hall
May 18 @ 11:00 am
... continue reading.
ML Board of Education Meeting 6:30 pm
ML Board of Education Meeting @ ML High School
May 20 @ 6:30 pm
... continue reading.
Environmental Commission Meeting 7:30 pm
Environmental Commission Meeting @ Zoom
May 21 @ 7:30 pm
Zoom Meeting ID: 826 2387 7229... continue reading.
Historic Preservation Committee Meeting 7:30 pm
Historic Preservation Committee Meeting @ ML Library
May 21 @ 7:30 pm
... continue reading.
Recreation Commission Meeting 7:30 pm
Recreation Commission Meeting @ Borough Hall
May 21 @ 7:30 pm – 8:30 pm
... continue reading.
Memorial Day Committee Meeting 8:00 pm
Memorial Day Committee Meeting @ DPW
May 21 @ 8:00 pm
... continue reading.
Planning Board Meeting 7:30 pm
Planning Board Meeting @ Borough Hall
May 23 @ 7:30 pm
... continue reading.
Borough Hall Closed-Memorial Day
Borough Hall Closed-Memorial Day
May 27 all-day
... continue reading.
Mountain Lakes Day 11:30 am
Mountain Lakes Day @ Esplanade
May 27 @ 11:30 am – 3:30 pm
MOUNTAIN LAKES DAY – MONDAY, MAY 30th – 11:30 – 3:30 PM Immediately following the Memorial Day Parade and Ceremonies, join us on The Esplanade (ML Train Station) to celebrate Mountain Lakes Day! Enjoy rides, carnival food, and connecting with neighbors! A fun-filled afternoon for the entire family! For more information or to reserve space for a display table, contact Jane Hayward.... continue reading.
Council meeting 8:00 pm
Council meeting @ Borough Hall
May 29 @ 8:00 pm
Borough Council Meeting... continue reading.
Concetta Bertoldi – Renowned Medium and NYT Best Selling Author 6:00 pm
Concetta Bertoldi – Renowned Medium and NYT Best Selling Author @ ML Club
May 31 @ 6:00 pm
Do dead people watch you shower? Discover the answer to this question and more by joining renowned Medium and New York Times Best Selling Author Concetta Bertaldi for a night of intrigue and "out of this world" connections presented for the first time ever by The Town Club of Mountain Lakes on Friday, May 31 at the Mountain Lakes Club, in Mountain Lakes. Concetta Bertoldi is the gifted and vivacious psychic medium featured in TIME Magazine and on The Early Show on CBS. Globally renowned for sharing heartfelt messages from the Other Side, Concetta delivers live shows to standing-room-only crowds where her natural wit and compassionate energy entertain and provide comfort to every life she touches. What: An Evening with Concetta Bertoldi: Medium & NYT Best Selling Author Date/Time: Friday, May 31, Doors open 6:00 pm with cash bar and light appetizers Show starts 7:00 pm Location: The Mountain Lakes Club, 18 Lake Dr., Mountain Lakes, NJ Admission: $65. Reserve tickets at: www.TownClubML.org "Town Club has a reputation for hosting unique and entertaining events that benefit dozens of charities, and this year, we're trying something totally 'above and beyond' by hosting Concetta Bertoldi," stated Town Club President Sueanne Sylvester. "Come early to enjoy cocktails and appetizers overlooking gorgeous Mountain Lake, then get ready to hear from the Other Side. Reserve your tickets early as seating is limited and Bertoldi's events generally sell out in advance." This event is one of two major fundraiser events for the Town Club to fund grants that are awarded annually to area service and education organizations that in the past have included: Arms Around Morris County, Family Promise of Morris County, Lake Drive Foundation Sound Start Babies, Lakeland Hills YMCA, North Porch Women's & Infants Center, Jersey Battered Women's Services, youth sports clubs, ML Schools and Public Library, the ML and Boonton Township Fire and Police Depts., and many more. Details at www.townclubml.org. ... continue reading.
|16 Thu
12:00 am
1:00 am
2:00 am
3:00 am
4:00 am
5:00 am
6:00 am
7:00 am
8:00 am
9:00 am
10:00 am
11:00 am
12:00 pm
1:00 pm
2:00 pm
3:00 pm
4:00 pm
5:00 pm
6:00 pm
7:00 pm
8:00 pm
9:00 pm
10:00 pm
11:00 pm

subset: commoncrawl


text:
! Armenian Alphabet ♬ IPA
This is the best way to learn the fascinating Armenian alphabet in all its forms: lowercase, UPPERCASE, matching cases, pronunciation, letter names, and numerals! Complete with audio as well as IPA and standard ISO 9985 romanization. Armenian keyboard layout not required. Please consider … Plus »
5.54k étudiant durée moyenne de 4h


text:
I was listening to a replay of the webcast recording on the HierarchyID by Michael Wang (thanks, Michael) and as he mentioned the considerations for the CLR-based type with respect to DDL, I thought it would be interesting to go back and see how this type showed up in the various facilities that we have for monitoring what SQLCLR is doing. These facilities are:
1. Ability to see assemblies registed in each database
2. Watch code-running appdomains (but not transient DDL-only appdomains) being created/torn down in SQL log
3. SQL Profiler event for Assembly.Load
4. Monitor memory and CLR-related processes using DMVs and perfmon
Before reporting the results obtained with SQL Server 2008 CTP4, we need a few clarifications. First, the way SQLCLR manages appdomains is an implementation detail and subject to change in future releases, service packs, or can even change before SQL Server 2008 ships. I'm just observing. Second, let's talk about what exactly the "sp_configure 'clr enabled', 0" does. You can also set this option using SQL Server Service Area Configuration utility. This option indicates whether or not its possible to run *user-written SQLCLR code*, that is, SQLCLR stored procedures, UDFs, trigger, UDTs, and UDAggs written by programmers.
The switch *does not*:
1. Keep SQLCLR from loading in SQL Server's process. This always loads the first time that you need it.
2. Prevent DBAs from using SQLCLR-related DDL, such as CREATE/ALTER/DROP ASSEMBLY, and define SQLCLR objects.
3. Prevent system functions that use SQLCLR from running. In SQL Server 2005, there were no SQLCLR system functions that I was aware of.
In SQL Server 2008, system functions that use SQLCLR that immediately come to mind include:
a. The HierarchyID and upcoming spatial data types, Geometry and Geography
b. Change Data Capture and the Dynamic Management Framework
So, its not that using system functions written in SQLCLR is "a trick" that bypasses an established control mechanism. The reality is that the mechanism was never defined to prevent SQLCLR loading, DDL, or system functions.
One things that will prevent SQLCLR from running is to enable lightweight pooling, or "fiber mode scheduling". This is also a configuration option, and its incompatible with SQLCLR. The CLR is not "fiber aware", although it may be implemented sometime in the future. A few other SQL Server system features are incompatible with fiber mode as well.


text:
Rory McIlroy is returning to a hell we'll likely never know. At last year's Masters, he held a commanding four-shot lead going into the final round, then infamously collapsed. With his lead already trimmed to one shot, things got real ugly on No. 10: his tee shot hit a tree and settled between two cabins deep in the woods. His putting coach said Augusta National should put a plaque on that spot: Here, ladies and gentlemen, was where young Rory lost it all. He triple bogeyed the hole, instantly fell two shots behind and wound up shooting a 43 on the back 9, finishing tied for 15th.
So imagine you're McIlroy stepping up to the 10th tee for the first time during tournament play. Or even better, picture him this Sunday, April 8, either with a lead or in contention — each a very likely scenario — returning to that hole of horrors. Won't McIlroy, 22, think about what happened a year ago? Going back to a painful place is never easy.
(PHOTOS: Rory McIlroy's Road to the Masters)
TIME called two prominent golf psychologists, both working with players in Augusta: Dr. Bob Rotella, who is advising Padraig Harrington, Trevor Immelman and others and also advised John Calipari and the NCAA champion Kentucky Wildcats at the Final Four in New Orleans; and Dr. Gio Valiante, shrink to Justin Rose and Sean O'Hair. We asked them what advice they'd offer McIlroy, the world's second ranked player, who did dominate last year's second major, the U.S. Open, upon his return to the 10th tee. What mind tricks could prevent another Masters meltdown? Here are three tips:
1. Laugh It Up. McIlroy is a fun guy. Right after his collapse, for example, he snapped a picture with 2011 Masters champ Charl Schwartzel as they took a plane to Malaysia on the way to a post-Masters tournament. He tweeted it out with the message: "Glad one of us has the green jacket on!"
Rotella noticed that on the back nine of Augusta, McIlroy changed. "He got a little serious," says Rotella. "He got out of his personality. He started acting like Tiger — he turned inward." Such a demeanor works for Woods but isn't really a fit for the Irishman, even though it's only natural for McIlroy, who like so many of today's young golfers grew up watching Woods dominate Augusta, to channel his golf hero.
McIlroy has pretty much admitted that trying to mimic Woods cost him. Rotella says McIlroy could take a lesson from the Kentucky hoops team: after the Wildcats missed some late free throws in their semifinal win against Louisville, they laughed about it in the postgame locker room. In the April 2 championship game, the relaxed Wildcats sank some key shots. "If he makes a few mistakes, he should just laugh about it," says Rotella. "It's just golf." In the days before this year's tournament, McIlroy has been yukking it up. Once he starts his rounds, he should bring the guffaws to the golf course.
(MORE: Why I'm Rooting for Tiger but Don't Want My Female Friends to Know)
2. Put Twain in Your Game. It's Sunday afternoon, and McIlroy has a one-stroke lead over his final-round partner, Tiger Woods. It's the dream matchup for golf fans everywhere. McIlroy is at the 10th tee and wants to look in the direction where he so horribly hooked that drive last year. Don't do it!
Rotella suggests that McIlroy think of a Mark Twain quote: "The inability to forget is infinitely more devastating than the inability to remember." Repeat it in his head, over and over. McIlroy needs to remind himself that if he's in contention on the back nine for a second straight year, he must be doing something right. "Stay in the present moment," Rotella says. "In golf, just play until you run out of holes. Add 'em up in the end and see how you did."
3. Soften Those Hands. When McIlroy returns to No. 10, he won't help but feel a little nervous. Valiante notes that once the stress hormones get released, the muscles tense. That's when golfers tighten their grip, which can throw off their swing and their rhythm. Valiante has a mantra for his pro patients: "Soft hands, soft hands." McIlroy should keep an eye on his grip. Loosen it up if it feels too tight, and the rest of his body may relax. "You can't always control your thoughts," says Valiente. "But you can always control your grip pressure."
So Rory, chuckle a bit, quote Mark Twain and keep your hands loose. That green jacket would look mighty good on you.
(MORE: Can an English (or Northern Irish) Golfer End Europe's Drought at the Masters?)


text:
It might be a great idea that launches your startup, but don't kid yourself--your company's fate depends on your team. We spoke with serial entrepreneur Naeem Zafar, who teaches entrepreneurship at the University of California, Berkeley, and is co-founder and CEO of enterprise mobility startup Bitzer Mobile, to walk us through the steps you should take to assemble a group that's built for success.
Stage 1
The Founders
The first and perhaps most difficult step is to evaluate your business partner(s). "The quality of people in this phase will define the DNA of the company later," Zafar says.
"It's critical to be ruthless … Ask yourself every day, In the whole world, are these the best people I could be working with?" If the answer is yes, it's time to designate roles and divide responsibilities.
"When we were starting our last company, we decided that for anything technical, my co-founder would make those decisions ultimately--so we would not debate them ad nauseam--and for anything business-related, I would make the decision," he says.
Even if you never use the words company culture, keep in mind that the decisions you make now are defining exactly that.
Tip: Now is the time to figure out the company's equity structure, determining the precise division among the partners. Doing so will prevent expensive problems later.
Stage 2
Advisors, part-timers, contract hires
Zafar says five types of advisors are essential to any startup: a market/domain expert, a connector (a well-connected person who isn't afraid to make introductions), an industry celebrity (who is willing to lend a name but not necessarily be directly involved), a personal coach and a technical expert who knows the industry inside and out. Attend industry events to meet potentials. "See who you have the right chemistry with, who is intrigued by your idea and who you can rely on," Zafar says.
As the business starts to grow and tasks start to go undone due to lack of time (or you just forgot), it's time to bring in extra personnel. Determine what skills and talents you and your partners lack and seek out part-timers and contractors to fill in the gaps. Zafar suggests searching LinkedIn for people with the expertise you need, then sending a straightforward e-mail requesting a few minutes of their time. "Typically four out of 10 people will say yes if you approach them honestly, correctly and with an interesting topic," he says.
Tip: When enlisting outside help, make sure you have recruits sign a legal agreement that enforces confidentiality and confirms that you retain ownership of the work.
Stage 3
Full-time staff
When should you hire your first full-time employees? Often, according to Zahar, finances will dictate your readiness to take this step. When you score an infusion of capital--whether through bootstrapping, a bank loan, a venture capital firm or even friends and family--you're ready to add staff and kick your company into a higher gear.
Take care to hire the best people you can, those who believe in your startup as much as you do. "The first five hires you make will tell the next 25 people whether they should come [work there] or not," Zafar says. He suggests administering two tests: a skill assessment and a presentation. "I want to see how they handle giving a presentation, how well they think on their feet, how comfortable they are. It's quite revealing," he says.
Tip: Zafar says one of the biggest mistakes made at this stage is underestimating the value of a product manager. "In my company, after the first two or three engineers are hired, the next is a product manager, because you really have to have somebody from the marketing side shaping the product," he says. "Otherwise you end up with a monstrosity."
Quality control
"You have to decide: Are you going to hire people who have major strengths or are you going to hire people that lack major weaknesses?" says Naeem Zafar, a faculty member who teaches entrepreneurship at the University of California, Berkeley. "The funny part is people who have major strengths also have major weaknesses … the ultimate example would be the New York Yankees, or a pirate ship, where everybody is extremely good and has extremely big egos and they almost can't stand each other, but as a team they somehow make it work. Not every founder is comfortable with that; most want harmony. But harmony doesn't create excellent products."


text:
Q. There seems to be a lot of variation in how people observe fasting, but my confessor told me to fast from oil on Wednesday and Friday. Oil is a pretty vague category, though, and I was wondering if I could get a more explicit description of what kinds of food and drink are excluded on strict fast days. Also, are there rules about how many meals you can eat? I know on some strict fast days, like the Exaltation, you are only meant to eat in the evening. Are there other days like this?
A. Fasting is an ascetical practice handed down to us from God since the creation of man. The first commandment He gave Adam and Eve was to abstain from a particular fruit. Fasting has been given to us, in part, in order that we learn self-control. It is part of one's spiritual life and as such one should always be under the guidance of a spiritual father. Such questions as the ones you pose should be directed to your spiritual father, especially since they involve the clarification of a rule he himself has given you. Practice differs between Orthodox of different nationalities. Even one and the same spiritual father may prescribe different fasting rules for different people. This is in keeping with the Church Fathers who teach that those who have received from God the power to loose and bind—that is the spiritual fathers—must use discretion, sometimes being stern, imposing the full weight of the law, at other times being lenient, condescending to weakness. But his intention is always the salvation of his spiritual child (c.f. Trullo Canon 102). This is why we cannot answer your question exactly, and you should consult your confessor.
Having said that, St. Nicodemus of the Holy Mountain outlines for us the ideal for which are striving in his interpretation of the 64th Apostolic Canon:
Fasting is one thing and leaving off fasting is another thing, and abolishing fasting is still another thing. Thus, fasting, properly speaking, is complete abstinence from food of all kinds, or even when one eats but once a day, about the ninth hour, dry food, or, more explicitly speaking, plain bread and water alone. Leaving off fasting is when one eats before the ninth hour, even though it be merely figs, or merely currants or raisins, or anything else of this kind; or if, besides bread and water, he should eat also some kinds of frugal and cheap comestibles, such as, for instance, legumes, wine, olive oil, or shellfish. Abolishing fasting on the other hand, is when one eats of all foodstuffs, including meat, say, and fish, and milk, and cheese, and the rest.
As for the various types of fast days, there are strict fast days and days on which oil, wine and seafood (shellfish) are permitted. Fish is also permitted certain fast days; on these days naturally we also partake of oil, wine and seafood (shellfish).
Iftar, refers to the evening meal when Muslims break their fast during the Islamic month of Ramadan. Iftar is one of the religious observances of Ramadan and is often done as a community, with people gathering to break their fast together. Iftar is done right after sunset.
We report the following unchanged as it was published:
"The leaders of the Armenian, Roman, Jewish and Syrian communities of Turkey sat around the fasting Iftar dinner in the Beyoglu district of Istanbul." Read more...
St. John of Kronstadt Orthodox Church began as a mission parish in the year 2000, in a home chapel in Palm Coast, FL – a small town on Florida's northeast coast located between St. Augustine and Daytona Beach. After two years, it became necessary to have services in area community centers, rented for Sundays and other Holy Days. Read more...
2023 Youth Conference
Please join us for the 2023 youth conference in Chicago, IL! To learn more, visit the home page or visit the conference website.
Q. This concerns a U.S. marriage. If the marriage is civilly annulled, what is the effect upon the Church marriage? Is it also annulled? Read more...


text:
Search the Community
Showing results for tags 'sourcesafe'.
Found 1 result
What is your Backup Process?
zeke posted a topic in Fireside ChatLast night, I discovered that one of my source code repo's had been lost. Today, I confirmed that I had no backup of that repo. I am feeling poorly now because I know that it was my fault. I should have had a backup process in place to prevent this type of loss. So now I am wondering, what is your data backup process? How do you ensure your data is not lost in the worst case scenario?


text:
The Evil Post
It's an odd quirk of our taste for "round" numbers that we tend to celebrate milestones that are multiples of a power of ten. For example, a 10th anniversary is somehow more significant than a 6th anniversary. Likewise, a 100th post is more significant than a 73rd post.
This post reaches a different sort of milestone, it is my 666th post. Yes, this post bears with it the mark of the beast. I dedicate this post to pure eeeeevil.
Not having a reputation evil, my first step is to gauge my current evil quotient via the "How evil are you?" website. Unfortunately I rated quite good on the Evil-o-meter. There was certainly work to do.
So chomped down on my Cuban cigar, fired up Internet Explorer (evil-o-meter rising) and navigated to the evil overload list. Using Powerpoint (+2 on the evil-o-meter) I copied the list verbatim (DMCA anyone?) and started committing them to memory.
After getting a bit bored, I spent a little time doing some stem cell research and even tried my hand at human cloning. I thought about having an abortion, but as I am male, had a tough time getting pregnant. So I changed tactics and bought an H2 and drove it into a nature preserve while smoking an illegal substance and drinking a forty.
At this point, I realized that to really get the evil-o-meter soaring, I should SPAM people. Not only should I create SPAM, I should write a web service to do so. I wrote one that returned an ADO.NET DataSet of email addresses and websites with comments enabled so that others could join in the SPAMination. Soon all the world would know about all the latest Texas Hold-Em websites.
Oh, did I mention that application is written with only one line of code? And there are no comments. And I used HTML Tables and NO CSS. It's covered in Hungarian Notation. And I have promoted it as an example of "SOA". And the application connects to the (non-normalized) database using the SA account without a password. I used inline sql without using parameterized queries. Yes, Satan himself is starting to get worried here. But then again, I personally didn't write this code, I off-shored it to a sweatshop in China that employs overworked six year olds to hack out the code.
After all this hard work, I relaxed to a game of Dungeons & Dragons while watching a little sesame street to absorb the evil that is Bert. This led to an internal debate about which character is more evil, Barney or Bert?
After studying this mathematical proof of Barney's evil and this essay, "Why is Barney Considered Evil", I concluded that indeed, Barney is more evil.
I considered creating a Marketing website without an RSS feed, but not even I was ready to go that far.
After all that, I went back to retake the evil survey. It turns out that I may have done a bit too much research as the site declared that I wasn't evil but clinically insane. Not bad for a day's work. I wonder what post should I dedicate to insanity?
[Listening to: Thriller - Michael Jackson - HIStory, Past, Present And Future, Book 1 (Compilation) (Disc 1) (5:57)]
4 responses
• July 2nd, 2005
I answer honestly to every question and got back
"You are Pure Evil
You are absolutely terrifying. Your mere presence strikes fear into the hearts of everyone around you. There is no turning back. You are the definition of evil, and probably work for an evil company like AOL."
Well, I'm off to take over the world....
• July 3rd, 2005
In the how evil are you suvey i can really mess the results. By changing my social clique from nerds to goths i go fron neutral to pure evil. I don't think its a great rank of evilness.
• July 16th, 2005
A masterpiece. They blew it when they rejected your application for the Axis of Evil.
• January 1st, 2007
your pure pure pure pure pure pure pure pure pure evillllllllllllllllllllllllllllllll


text:
State Bank Of India Babatpur IFSC & Branch Info
The IFSC Code of State Bank Of India Babatpur branch is SBIN0032129. The branch is located in Babatpur district of Uttar Pradesh. For address and phone numbers, scroll down.
SBI Babatpur IFSC Code: SBIN0032129
State Bank Of India Babatpur MICR & Contact Info
Address, MICR code, branch contact number etc of SBI Babatpur branch is given below. You may contact the branch or the Customer Care number of the bank information relating to your State Bank Of India account.
|Branch Name
|State Bank Of India Babatpur
Babatpur-basni Road, Babatpur, Varanasi, UP - 221006
City : Varanasi
District : Babatpur
State : Uttar Pradesh
|Branch Phone Number
|Customer Care Number
|1800-11-2211, 1800-425-3800
SBI branches in Babatpur | SBI branches in Uttar Pradesh
Along with your account number, account name and account type (ie., savings or current) the following information about the branch is to be provided for fund transfer:
Bank Name : State Bank Of India
Branch Name : Babatpur
IFSC Code : SBIN0032129
Location : Varanasi, Babatpur, Uttar Pradesh - View full address & contact number
To make NEFT or RTGS money transfer to State Bank Of India Babatpur branch from any other bank in India, IFSC code is necessary. For hustle free payment transfer, share the accurate IFSC, branch name and account number with the transferer.


text:
Skip to main content
Skip to main content
Labour and birth
Pain relief in labour
Open all pages about Labour and birth
Main navigation
What happens in labour and birth
Pain relief in labour
The stages of labour and birth
Tips for your birth partner
Giving birth to twins or more
Pain relief in labour
Episiotomy and perineal tears
Forceps or vacuum delivery
What happens if your baby is breech?
What complications can affect the placenta?
Page last reviewed: 13/03/2023
Next review due: 13/03/2026


text:
AEM 6.4 has reached the end of extended support and this documentation is no longer updated. For further details, see our technical support periods. Find the supported versions here.
Since the touch-enabled UI supersedes the classic UI, the user or administrator of the AEM instance must make an active decision to continue using the classic UI. Because the classic UI is no longer maintained, there is no way for the authoring user to simply switch from the classic UI to the equivalent in the touch-enabled UI.
For convenience to authoring users, the touch-enabled UI does allow for switching to the classic UI when necessary. See the Selecting your UI in the standard Authoring documentation for details.
Instances upgraded from a previous version will retain the classic UI for page authoring.
After upgrade, page authoring will not be automatically switched to the touch-enabled UI, but you can configure this using the OSGi configuration of the WCM Authoring UI Mode Service (
AuthoringUIMode service). See UI Overrides for the Editor.
A system administrator can configure the UI that is seen at startup and login by using Root Mapping.
This can be overridden by user defaults or session settings.


text:
DEAR ABBY: I'm a 23-year-old woman who still lives at home. I have been working for the last five years and have saved enough to live comfortably on my own. Unfortunately, my parents have forbidden me to do it because they think I'm being manipulated into it by my boyfriend, that I just want to "do whatever I want" and be out until late (although I'm rarely up past 9 p.m. and they know it), and because I "can't stand them" anymore.
I have no privacy! My mail is opened "mistakenly" and my calls are listened in on even when I politely -- and sometimes angrily -- ask them not to. They have even imposed a rule that I must show them my bank balance weekly.
They have told me I will not leave the house without being married first. I would like to live on my own before I actually marry so I can experience what it's like. This is something I have always wanted to do. If I do move out, they say I'll "bring shame and embarrassment" to the family.
There seems to be a double standard going on here because my older brother has his girlfriend sleep over. How can I accommodate my parents without being disowned? -- FEELING HELPLESS IN ILLINOIS
DEAR FEELING HELPLESS: Your parents have chosen to ignore that you are an adult, self-supporting and entitled to make your own choices. They may be well-meaning, but they are extremely heavy-handed. Their hyper-vigilance -- opening your mail, eavesdropping on your phone calls and insisting on checking your bank balance weekly -- is over the top. They would like you to be "safely" married before you leave their protection.
Is their problem that they disapprove of your boyfriend? If you get a place of your own, do you plan on moving him in? If that's not the case, there is no reason why your living independently might shame or embarrass them.
Not knowing your parents, I can't judge whether their threat to disown you is serious or not. However, if it is, realize it's a form of blackmail, and you will have to decide which is more important -- your freedom or their support.


text:
He is expected to step aside as majority leader on July 31. The decision sets up a leadership scramble among Republicans in the House, which is led by Speaker John Boehner of Ohio.
The heavily favored Cantor lost Tuesday to college professor and political novice Dave Brat, who triumphed in the Richmond-area district with tea party support.
Cantor is expected to address reporters later on Wednesday.
Most Republicans had viewed Cantor, 51, as the most conservative member in the House leadership and a likely successor to Boehner.
Republican sources said Boehner is more likely to stay on and help build a new leadership team without a clear successor.
Boehner on Wednesday called Cantor a "good friend" and a "good leader" for Republicans.
Conservative members are already demanding someone from a red state be elected to represent their views at the leadership table.
The election for Cantor's GOP position is next Thursday, according to two Republican sources.
Rep. Pete Sessions of Texas told reporters he's planning to run for Cantor's post. Current House GOP Whip Kevin McCarthy of California also is expected to do so, but Rep. Cathy McMorris Rodgers of Washington State, the top women on the leadership team, will stay put.
GOP strategist John Feehery, formerly a top Republican congressional aide, said Cantor's defeat throws the GOP conference into chaos and will make it harder to get anything done.
Although Cantor dramatically outspent Brat in Virginia's 7th Congressional District race and most political observers anticipated he would win easily, the cash advantage didn't alter the outcome and he lost convincingly.
Cantor fell by 10 percentage points although turnout was low.
"Eric Cantor lost this race as much as Dave Brat won it. He simply violated rule number one of politics: go home," said CNN Chief National Correspondent John King. "This is Eric Cantor's fault. He was in Washington on primary day. Not back in his district."
Brat ran an anti-establishment campaign, hitting Cantor for his ties to Washington and characterizing him as out-of-touch with Virginians.
He also slammed Cantor's support for proposals allowing children of those who enter the country illegally the ability to obtain some type of legal status, chalking the stance up to amnesty and insisting Cantor's views would hurt the economy.
Brat, who predicted a shocker on Tuesday, is an economics professor at Randolph-Macon College. His Democratic opponent in November, Jack Trammell, also teaches at the school outside Richmond. Trammell was nominated at a party convention and is thought to have a very tough road ahead.


text:
Search Results
Thrust Ward IV
Equippable Amulet
Equippable Ring
Equippable Token
|+3.75% Thrust Damage Absorption.
Thrust Ward IV is a Perk in New World, used in the Armor, Equippable Amulet, Equippable Ring & Equippable Token slot of certain Equipment and absorbs +3.75% Thrust Damage. Perks can be found in certain Equipment, and grant the player different types of bonuses, be it offensive or defensive, such as boosting damage output, granting resistance to a certain element or even increasing the amount of resources Gathering skills yield.
Thrust Ward IV Effect
+3.75% Thrust Damage Absorption.
Equipment that has Thrust Ward IV
- equipment goes here...
Thrust Ward IV Notes and Tips
- Notes & Tips go here
Join the page discussion Tired of anon posting? Register!
Load more